Clinical trial · Interventional
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event. The investigators' hypotheses include the following: 1. Compared to in-person assessment, store-and-forward teledermatology assessment will result in adequate diagnostic concordance. 2. Compared to in-person assessment, store-and-forward teledermatology results in adequate management concordance. 3. The sensitivity and specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant will be similar to that of in-person evaluation.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Screening | — | UNRESOLVED | — |
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
| Telemedicine | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| In-person dermatology evaluation | Other | — | UNRESOLVED |
| Store-and-forward teledermatology evaluation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- In-person dermatology evaluation
- description
- Health care modality
- interventionNames
- Other: In-person dermatology evaluation
- type
- OTHER
- label
- Store-and-forward teledermatology evaluation
- description
- Health care modality
- interventionNames
- Other: Store-and-forward teledermatology evaluation
Primary outcomes (1)
- measure
- Aggregated diagnostic concordance
- timeFrame
- At the time of dermatologist evaluation (Day 1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years of age or older at time of consent, may be male or female. * Able to provide a brief medical history and have/allow an examination of their skin including photographs. * Capable of giving informed consent. * Will be able to receive notification of follow-up recommendations Exclusion Criteria: * Patients who will not provide informed consent * Patient who are unable to fulfill tasks of this study
References
Publications (0)
Data not yet available